Dimensional Fund Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-371,752
Closed -$357K 3544
2023
Q2
$357K Sell
371,752
-40
-0% -$40 ﹤0.01% 3131
2023
Q1
$279K Sell
371,792
-67,931
-15% -$49.6K ﹤0.01% 3139
2022
Q4
$162 Hold
439,723
﹤0.01% 3262
2022
Q3
$189K Sell
439,723
-20,162
-4% -$19.8K ﹤0.01% 3250
2022
Q2
$358K Sell
459,885
-70,060
-13% -$61.7K ﹤0.01% 3141
2022
Q1
$683K Sell
529,945
-390,778
-42% -$360K ﹤0.01% 3078
2021
Q4
$1.17M Sell
920,723
-483,203
-34% -$864K ﹤0.01% 2994
2021
Q3
$3.06M Sell
1,403,926
-433,727
-24% -$1.19M ﹤0.01% 2725
2021
Q2
$6.89M Sell
1,837,653
-158,149
-8% -$550K ﹤0.01% 2504
2021
Q1
$6.53M Buy
1,995,802
+361,571
+22% +$1.3M ﹤0.01% 2482
2020
Q4
$5.58M Sell
1,634,231
-278,410
-15% -$1.15M ﹤0.01% 2493
2020
Q3
$7.8M Buy
1,912,641
+122,287
+7% +$465K ﹤0.01% 2307
2020
Q2
$6.05M Sell
1,790,354
-39,223
-2% -$114K ﹤0.01% 2410
2020
Q1
$4.26M Buy
1,829,577
+300,380
+20% +$822K ﹤0.01% 2475
2019
Q4
$5.57M Buy
1,529,197
+216,213
+16% +$1.75M ﹤0.01% 2574
2019
Q3
$10.9M Buy
1,312,984
+85,345
+7% +$690K ﹤0.01% 2310
2019
Q2
$10.6M Buy
1,227,639
+215,734
+21% +$1.93M ﹤0.01% 2377
2019
Q1
$10.8M Buy
1,011,905
+11,660
+1% +$125K ﹤0.01% 2372
2018
Q4
$8.75M Buy
1,000,245
+263,961
+36% +$3.36M ﹤0.01% 2404
2018
Q3
$12.4M Sell
736,284
-382,753
-34% -$8.28M ﹤0.01% 2341
2018
Q2
$23.5M Sell
1,119,037
-1,298,911
-54% -$24.1M 0.01% 2023
2018
Q1
$38.9M Sell
2,417,948
-44,959
-2% -$891K 0.02% 1595
2017
Q4
$46.7M Sell
2,462,907
-81,994
-3% -$1.49M 0.02% 1427
2017
Q3
$35.8M Sell
2,544,901
-129,778
-5% -$1.17M 0.02% 1631
2017
Q2
$19.9M Buy
2,674,679
+463,434
+21% +$3.03M 0.01% 2030
2017
Q1
$14.4M Buy
2,211,245
+240,614
+12% +$1.35M 0.01% 2161
2016
Q4
$8.73M Buy
1,970,631
+181,018
+10% +$759K ﹤0.01% 2356
2016
Q3
$8.36M Buy
1,789,613
+402,850
+29% +$2.39M ﹤0.01% 2323
2016
Q2
$9.11M Buy
1,386,763
+162,704
+13% +$1.15M 0.01% 2267
2016
Q1
$7.79M Buy
1,224,059
+20,932
+2% +$107K ﹤0.01% 2311
2015
Q4
$7.25M Sell
1,203,127
-32,031
-3% -$183K ﹤0.01% 2361
2015
Q3
$7.39M Sell
1,235,158
-2,844
-0.2% -$19.7K ﹤0.01% 2355
2015
Q2
$8.47M Sell
1,238,002
-13,648
-1% -$86.7K 0.01% 2355
2015
Q1
$7.6M Sell
1,251,650
-1,817
-0.1% -$12.1K ﹤0.01% 2372
2014
Q4
$8.69M Buy
1,253,467
+8,900
+0.7% +$65.4K 0.01% 2332
2014
Q3
$10.1M Sell
1,244,567
-3,673
-0.3% -$28.7K 0.01% 2196
2014
Q2
$10.1M Sell
1,248,240
-6,075
-0.5% -$46.1K 0.01% 2214
2014
Q1
$9.83M Sell
1,254,315
-4,600
-0.4% -$38.9K 0.01% 2202
2013
Q4
$11.1M Sell
1,258,915
-15,330
-1% -$137K 0.01% 2073
2013
Q3
$10.7M Sell
1,274,245
-18,746
-1% -$152K 0.01% 2061
2013
Q2
$9.65M Buy
+1,292,991
New +$9.92M 0.01% 2033

Dimensional Fund Advisors's SPPI Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 371,752 shares — an estimated $357K sold.

Dimensional Fund Advisors first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $46.7M in Q4 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 371,752 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $357K.
  • Dimensional Fund Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
  • Dimensional Fund Advisors's Spectrum Pharmaceuticals Inc position peaked at $46.7M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.